nodes	percent_of_prediction	percent_of_DWPC	metapath
Levofloxacin—ABCB1—kidney cancer	0.204	1	CbGaD
Levofloxacin—TOP2A—Doxorubicin—kidney cancer	0.0566	0.122	CbGbCtD
Levofloxacin—SLC22A2—Vinblastine—kidney cancer	0.0463	0.0996	CbGbCtD
Levofloxacin—ABCB1—Temsirolimus—kidney cancer	0.0409	0.088	CbGbCtD
Levofloxacin—CYP3A4—Everolimus—kidney cancer	0.0363	0.0781	CbGbCtD
Levofloxacin—CYP1A2—Pazopanib—kidney cancer	0.0246	0.0529	CbGbCtD
Levofloxacin—CYP3A4—Temsirolimus—kidney cancer	0.0245	0.0528	CbGbCtD
Levofloxacin—ABCB1—Pazopanib—kidney cancer	0.0215	0.0462	CbGbCtD
Levofloxacin—ABCB1—Dactinomycin—kidney cancer	0.0197	0.0423	CbGbCtD
Levofloxacin—CYP1A2—Erlotinib—kidney cancer	0.0175	0.0377	CbGbCtD
Levofloxacin—ABCB1—Gemcitabine—kidney cancer	0.0155	0.0334	CbGbCtD
Levofloxacin—ABCB1—Erlotinib—kidney cancer	0.0153	0.033	CbGbCtD
Levofloxacin—CYP1A2—Sorafenib—kidney cancer	0.0143	0.0307	CbGbCtD
Levofloxacin—ABCB1—Paclitaxel—kidney cancer	0.014	0.0302	CbGbCtD
Levofloxacin—CYP3A4—Pazopanib—kidney cancer	0.0129	0.0277	CbGbCtD
Levofloxacin—ABCB1—Sorafenib—kidney cancer	0.0125	0.0268	CbGbCtD
Levofloxacin—ABCB1—Vinblastine—kidney cancer	0.0123	0.0265	CbGbCtD
Levofloxacin—ABCB1—Vincristine—kidney cancer	0.0121	0.0261	CbGbCtD
Levofloxacin—ABCB1—Sunitinib—kidney cancer	0.0101	0.0217	CbGbCtD
Levofloxacin—CYP3A4—Erlotinib—kidney cancer	0.00919	0.0198	CbGbCtD
Levofloxacin—SLC22A2—nephron—kidney cancer	0.0085	0.26	CbGeAlD
Levofloxacin—CYP3A4—Paclitaxel—kidney cancer	0.00841	0.0181	CbGbCtD
Levofloxacin—ABCB1—Doxorubicin—kidney cancer	0.00757	0.0163	CbGbCtD
Levofloxacin—CYP3A4—Sorafenib—kidney cancer	0.00747	0.0161	CbGbCtD
Levofloxacin—CYP3A4—Vinblastine—kidney cancer	0.00738	0.0159	CbGbCtD
Levofloxacin—CYP3A4—Vincristine—kidney cancer	0.00725	0.0156	CbGbCtD
Levofloxacin—CYP3A4—Sunitinib—kidney cancer	0.00605	0.013	CbGbCtD
Levofloxacin—CYP3A4—Doxorubicin—kidney cancer	0.00453	0.00976	CbGbCtD
Levofloxacin—CYP1A2—urine—kidney cancer	0.00303	0.0926	CbGeAlD
Levofloxacin—CYP3A4—urine—kidney cancer	0.00219	0.0671	CbGeAlD
Levofloxacin—SLC22A6—nephron tubule—kidney cancer	0.00199	0.0608	CbGeAlD
Levofloxacin—SLC22A2—nephron tubule—kidney cancer	0.00183	0.0561	CbGeAlD
Levofloxacin—SLC22A6—cortex of kidney—kidney cancer	0.0017	0.0521	CbGeAlD
Levofloxacin—SLC22A2—renal system—kidney cancer	0.00167	0.051	CbGeAlD
Levofloxacin—SLC22A2—kidney—kidney cancer	0.00161	0.0493	CbGeAlD
Levofloxacin—SLC22A2—cortex of kidney—kidney cancer	0.00157	0.048	CbGeAlD
Levofloxacin—SLC22A4—nephron tubule—kidney cancer	0.00136	0.0416	CbGeAlD
Levofloxacin—SLC22A4—renal system—kidney cancer	0.00124	0.0378	CbGeAlD
Levofloxacin—SLC22A4—kidney—kidney cancer	0.0012	0.0366	CbGeAlD
Levofloxacin—SLC22A4—cortex of kidney—kidney cancer	0.00116	0.0356	CbGeAlD
Levofloxacin—TOP2A—Docetaxel—Paclitaxel—kidney cancer	0.000946	0.227	CbGdCrCtD
Levofloxacin—CYP1A2—renal system—kidney cancer	0.000742	0.0227	CbGeAlD
Levofloxacin—CYP3A4—renal system—kidney cancer	0.000537	0.0164	CbGeAlD
Levofloxacin—CYP3A4—kidney—kidney cancer	0.000519	0.0159	CbGeAlD
Levofloxacin—TOP2A—Vindesine—Vinblastine—kidney cancer	0.000481	0.115	CbGdCrCtD
Levofloxacin—TOP2A—Vindesine—Vincristine—kidney cancer	0.000481	0.115	CbGdCrCtD
Levofloxacin—TOP2A—Gefitinib—Erlotinib—kidney cancer	0.000453	0.109	CbGdCrCtD
Levofloxacin—ABCB1—nephron tubule—kidney cancer	0.000418	0.0128	CbGeAlD
Levofloxacin—ABCB1—renal system—kidney cancer	0.00038	0.0116	CbGeAlD
Levofloxacin—ABCB1—kidney—kidney cancer	0.000367	0.0112	CbGeAlD
Levofloxacin—ABCB1—cortex of kidney—kidney cancer	0.000358	0.0109	CbGeAlD
Levofloxacin—ABCB1—gonad—kidney cancer	0.000341	0.0104	CbGeAlD
Levofloxacin—TOP2A—Vinorelbine—Vincristine—kidney cancer	0.000304	0.0728	CbGdCrCtD
Levofloxacin—TOP2A—Vinorelbine—Vinblastine—kidney cancer	0.000304	0.0728	CbGdCrCtD
Levofloxacin—TOP2A—Vincristine—Vinblastine—kidney cancer	0.00026	0.0623	CbGdCrCtD
Levofloxacin—TOP2A—Vinblastine—Vincristine—kidney cancer	0.000209	0.0501	CbGdCrCtD
Levofloxacin—Norfloxacin—CYP1A1—kidney cancer	0.000173	0.39	CrCbGaD
Levofloxacin—TOP2A—Cytarabine—Gemcitabine—kidney cancer	0.000171	0.0409	CbGdCrCtD
Levofloxacin—Sparfloxacin—ABCB1—kidney cancer	0.000161	0.363	CrCbGaD
Levofloxacin—TOP2A—Epirubicin—Doxorubicin—kidney cancer	0.000146	0.0351	CbGdCrCtD
Levofloxacin—TOP2A—Daunorubicin—Doxorubicin—kidney cancer	0.000146	0.0351	CbGdCrCtD
Levofloxacin—TOP2A—Idarubicin—Doxorubicin—kidney cancer	0.000146	0.0351	CbGdCrCtD
Levofloxacin—TOP2A—Azacitidine—Gemcitabine—kidney cancer	0.000122	0.0293	CbGdCrCtD
Levofloxacin—Ciprofloxacin—ABCB1—kidney cancer	0.000109	0.247	CrCbGaD
Levofloxacin—Dizziness—Sunitinib—kidney cancer	4.82e-05	0.000181	CcSEcCtD
Levofloxacin—Feeling abnormal—Gemcitabine—kidney cancer	4.82e-05	0.000181	CcSEcCtD
Levofloxacin—Shock—Paclitaxel—kidney cancer	4.82e-05	0.000181	CcSEcCtD
Levofloxacin—Vomiting—Sorafenib—kidney cancer	4.81e-05	0.000181	CcSEcCtD
Levofloxacin—Orthostatic hypotension—Doxorubicin—kidney cancer	4.81e-05	0.000181	CcSEcCtD
Levofloxacin—Nervous system disorder—Paclitaxel—kidney cancer	4.8e-05	0.000181	CcSEcCtD
Levofloxacin—Hypokalaemia—Doxorubicin—kidney cancer	4.8e-05	0.00018	CcSEcCtD
Levofloxacin—Thrombocytopenia—Paclitaxel—kidney cancer	4.79e-05	0.00018	CcSEcCtD
Levofloxacin—Tachycardia—Paclitaxel—kidney cancer	4.78e-05	0.00018	CcSEcCtD
Levofloxacin—Rash—Sorafenib—kidney cancer	4.77e-05	0.00018	CcSEcCtD
Levofloxacin—Dermatitis—Sorafenib—kidney cancer	4.77e-05	0.000179	CcSEcCtD
Levofloxacin—Back pain—Capecitabine—kidney cancer	4.76e-05	0.000179	CcSEcCtD
Levofloxacin—Breast disorder—Doxorubicin—kidney cancer	4.76e-05	0.000179	CcSEcCtD
Levofloxacin—Skin disorder—Paclitaxel—kidney cancer	4.76e-05	0.000179	CcSEcCtD
Levofloxacin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	4.74e-05	0.000178	CcSEcCtD
Levofloxacin—Headache—Sorafenib—kidney cancer	4.74e-05	0.000178	CcSEcCtD
Levofloxacin—Muscle spasms—Capecitabine—kidney cancer	4.73e-05	0.000178	CcSEcCtD
Levofloxacin—Hyperhidrosis—Paclitaxel—kidney cancer	4.73e-05	0.000178	CcSEcCtD
Levofloxacin—Diarrhoea—Dactinomycin—kidney cancer	4.72e-05	0.000177	CcSEcCtD
Levofloxacin—Nasopharyngitis—Doxorubicin—kidney cancer	4.71e-05	0.000177	CcSEcCtD
Levofloxacin—Anorexia—Paclitaxel—kidney cancer	4.67e-05	0.000175	CcSEcCtD
Levofloxacin—Gastritis—Doxorubicin—kidney cancer	4.66e-05	0.000175	CcSEcCtD
Levofloxacin—Vision blurred—Capecitabine—kidney cancer	4.64e-05	0.000174	CcSEcCtD
Levofloxacin—Vomiting—Sunitinib—kidney cancer	4.63e-05	0.000174	CcSEcCtD
Levofloxacin—Body temperature increased—Gemcitabine—kidney cancer	4.62e-05	0.000174	CcSEcCtD
Levofloxacin—Tremor—Capecitabine—kidney cancer	4.61e-05	0.000173	CcSEcCtD
Levofloxacin—Rash—Sunitinib—kidney cancer	4.59e-05	0.000173	CcSEcCtD
Levofloxacin—Dermatitis—Sunitinib—kidney cancer	4.59e-05	0.000173	CcSEcCtD
Levofloxacin—Abdominal distension—Doxorubicin—kidney cancer	4.58e-05	0.000172	CcSEcCtD
Levofloxacin—Hypotension—Paclitaxel—kidney cancer	4.57e-05	0.000172	CcSEcCtD
Levofloxacin—Ill-defined disorder—Capecitabine—kidney cancer	4.57e-05	0.000172	CcSEcCtD
Levofloxacin—Headache—Sunitinib—kidney cancer	4.57e-05	0.000172	CcSEcCtD
Levofloxacin—Asthma—Doxorubicin—kidney cancer	4.55e-05	0.000171	CcSEcCtD
Levofloxacin—Dysphagia—Doxorubicin—kidney cancer	4.55e-05	0.000171	CcSEcCtD
Levofloxacin—Anaemia—Capecitabine—kidney cancer	4.55e-05	0.000171	CcSEcCtD
Levofloxacin—Hypersensitivity—Vincristine—kidney cancer	4.54e-05	0.000171	CcSEcCtD
Levofloxacin—Eosinophilia—Doxorubicin—kidney cancer	4.51e-05	0.00017	CcSEcCtD
Levofloxacin—Nausea—Sorafenib—kidney cancer	4.5e-05	0.000169	CcSEcCtD
Levofloxacin—Pancreatitis—Doxorubicin—kidney cancer	4.46e-05	0.000168	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	4.46e-05	0.000168	CcSEcCtD
Levofloxacin—Malaise—Capecitabine—kidney cancer	4.44e-05	0.000167	CcSEcCtD
Levofloxacin—Angina pectoris—Doxorubicin—kidney cancer	4.44e-05	0.000167	CcSEcCtD
Levofloxacin—Insomnia—Paclitaxel—kidney cancer	4.43e-05	0.000166	CcSEcCtD
Levofloxacin—Vertigo—Capecitabine—kidney cancer	4.42e-05	0.000166	CcSEcCtD
Levofloxacin—Asthenia—Vincristine—kidney cancer	4.42e-05	0.000166	CcSEcCtD
Levofloxacin—Syncope—Capecitabine—kidney cancer	4.41e-05	0.000166	CcSEcCtD
Levofloxacin—Leukopenia—Capecitabine—kidney cancer	4.41e-05	0.000166	CcSEcCtD
Levofloxacin—Paraesthesia—Paclitaxel—kidney cancer	4.4e-05	0.000165	CcSEcCtD
Levofloxacin—Vomiting—Dactinomycin—kidney cancer	4.39e-05	0.000165	CcSEcCtD
Levofloxacin—Bronchitis—Doxorubicin—kidney cancer	4.38e-05	0.000165	CcSEcCtD
Levofloxacin—Dyspnoea—Paclitaxel—kidney cancer	4.36e-05	0.000164	CcSEcCtD
Levofloxacin—Somnolence—Paclitaxel—kidney cancer	4.35e-05	0.000164	CcSEcCtD
Levofloxacin—Palpitations—Capecitabine—kidney cancer	4.35e-05	0.000164	CcSEcCtD
Levofloxacin—Rash—Dactinomycin—kidney cancer	4.35e-05	0.000164	CcSEcCtD
Levofloxacin—Nausea—Sunitinib—kidney cancer	4.33e-05	0.000163	CcSEcCtD
Levofloxacin—Loss of consciousness—Capecitabine—kidney cancer	4.33e-05	0.000163	CcSEcCtD
Levofloxacin—Pancytopenia—Doxorubicin—kidney cancer	4.32e-05	0.000163	CcSEcCtD
Levofloxacin—Dyspepsia—Paclitaxel—kidney cancer	4.31e-05	0.000162	CcSEcCtD
Levofloxacin—Cough—Capecitabine—kidney cancer	4.3e-05	0.000162	CcSEcCtD
Levofloxacin—Dysuria—Doxorubicin—kidney cancer	4.26e-05	0.00016	CcSEcCtD
Levofloxacin—Neutropenia—Doxorubicin—kidney cancer	4.26e-05	0.00016	CcSEcCtD
Levofloxacin—Decreased appetite—Paclitaxel—kidney cancer	4.26e-05	0.00016	CcSEcCtD
Levofloxacin—Hypertension—Capecitabine—kidney cancer	4.25e-05	0.00016	CcSEcCtD
Levofloxacin—Upper respiratory tract infection—Doxorubicin—kidney cancer	4.23e-05	0.000159	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Paclitaxel—kidney cancer	4.23e-05	0.000159	CcSEcCtD
Levofloxacin—Fatigue—Paclitaxel—kidney cancer	4.22e-05	0.000159	CcSEcCtD
Levofloxacin—Diarrhoea—Vincristine—kidney cancer	4.22e-05	0.000159	CcSEcCtD
Levofloxacin—Pollakiuria—Doxorubicin—kidney cancer	4.21e-05	0.000158	CcSEcCtD
Levofloxacin—Asthenia—Gemcitabine—kidney cancer	4.2e-05	0.000158	CcSEcCtD
Levofloxacin—Myalgia—Capecitabine—kidney cancer	4.19e-05	0.000158	CcSEcCtD
Levofloxacin—Arthralgia—Capecitabine—kidney cancer	4.19e-05	0.000158	CcSEcCtD
Levofloxacin—Chest pain—Capecitabine—kidney cancer	4.19e-05	0.000158	CcSEcCtD
Levofloxacin—Constipation—Paclitaxel—kidney cancer	4.19e-05	0.000157	CcSEcCtD
Levofloxacin—Pain—Paclitaxel—kidney cancer	4.19e-05	0.000157	CcSEcCtD
Levofloxacin—Anxiety—Capecitabine—kidney cancer	4.18e-05	0.000157	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	4.16e-05	0.000156	CcSEcCtD
Levofloxacin—Photosensitivity reaction—Doxorubicin—kidney cancer	4.16e-05	0.000156	CcSEcCtD
Levofloxacin—Discomfort—Capecitabine—kidney cancer	4.14e-05	0.000156	CcSEcCtD
Levofloxacin—Pruritus—Gemcitabine—kidney cancer	4.14e-05	0.000156	CcSEcCtD
Levofloxacin—Weight decreased—Doxorubicin—kidney cancer	4.12e-05	0.000155	CcSEcCtD
Levofloxacin—Hyperglycaemia—Doxorubicin—kidney cancer	4.11e-05	0.000154	CcSEcCtD
Levofloxacin—Dry mouth—Capecitabine—kidney cancer	4.1e-05	0.000154	CcSEcCtD
Levofloxacin—Nausea—Dactinomycin—kidney cancer	4.1e-05	0.000154	CcSEcCtD
Levofloxacin—Pneumonia—Doxorubicin—kidney cancer	4.08e-05	0.000154	CcSEcCtD
Levofloxacin—Dizziness—Vincristine—kidney cancer	4.08e-05	0.000153	CcSEcCtD
Levofloxacin—Infestation—Doxorubicin—kidney cancer	4.06e-05	0.000153	CcSEcCtD
Levofloxacin—Drowsiness—Doxorubicin—kidney cancer	4.06e-05	0.000153	CcSEcCtD
Levofloxacin—Infestation NOS—Doxorubicin—kidney cancer	4.06e-05	0.000153	CcSEcCtD
Levofloxacin—Confusional state—Capecitabine—kidney cancer	4.05e-05	0.000152	CcSEcCtD
Levofloxacin—Feeling abnormal—Paclitaxel—kidney cancer	4.03e-05	0.000152	CcSEcCtD
Levofloxacin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	4.03e-05	0.000151	CcSEcCtD
Levofloxacin—Oedema—Capecitabine—kidney cancer	4.02e-05	0.000151	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Paclitaxel—kidney cancer	4e-05	0.000151	CcSEcCtD
Levofloxacin—Diarrhoea—Gemcitabine—kidney cancer	4e-05	0.00015	CcSEcCtD
Levofloxacin—Renal failure—Doxorubicin—kidney cancer	3.99e-05	0.00015	CcSEcCtD
Levofloxacin—Infection—Capecitabine—kidney cancer	3.99e-05	0.00015	CcSEcCtD
Levofloxacin—Neuropathy peripheral—Doxorubicin—kidney cancer	3.98e-05	0.00015	CcSEcCtD
Levofloxacin—Stomatitis—Doxorubicin—kidney cancer	3.96e-05	0.000149	CcSEcCtD
Levofloxacin—Jaundice—Doxorubicin—kidney cancer	3.96e-05	0.000149	CcSEcCtD
Levofloxacin—Shock—Capecitabine—kidney cancer	3.95e-05	0.000149	CcSEcCtD
Levofloxacin—Conjunctivitis—Doxorubicin—kidney cancer	3.95e-05	0.000148	CcSEcCtD
Levofloxacin—Nervous system disorder—Capecitabine—kidney cancer	3.94e-05	0.000148	CcSEcCtD
Levofloxacin—Thrombocytopenia—Capecitabine—kidney cancer	3.93e-05	0.000148	CcSEcCtD
Levofloxacin—Tachycardia—Capecitabine—kidney cancer	3.92e-05	0.000147	CcSEcCtD
Levofloxacin—Vomiting—Vincristine—kidney cancer	3.92e-05	0.000147	CcSEcCtD
Levofloxacin—Skin disorder—Capecitabine—kidney cancer	3.9e-05	0.000147	CcSEcCtD
Levofloxacin—Urticaria—Paclitaxel—kidney cancer	3.89e-05	0.000146	CcSEcCtD
Levofloxacin—Rash—Vincristine—kidney cancer	3.89e-05	0.000146	CcSEcCtD
Levofloxacin—Hyperhidrosis—Capecitabine—kidney cancer	3.88e-05	0.000146	CcSEcCtD
Levofloxacin—Dermatitis—Vincristine—kidney cancer	3.88e-05	0.000146	CcSEcCtD
Levofloxacin—Haematuria—Doxorubicin—kidney cancer	3.87e-05	0.000146	CcSEcCtD
Levofloxacin—Abdominal pain—Paclitaxel—kidney cancer	3.87e-05	0.000146	CcSEcCtD
Levofloxacin—Body temperature increased—Paclitaxel—kidney cancer	3.87e-05	0.000146	CcSEcCtD
Levofloxacin—Headache—Vincristine—kidney cancer	3.86e-05	0.000145	CcSEcCtD
Levofloxacin—Hepatobiliary disease—Doxorubicin—kidney cancer	3.84e-05	0.000144	CcSEcCtD
Levofloxacin—Epistaxis—Doxorubicin—kidney cancer	3.83e-05	0.000144	CcSEcCtD
Levofloxacin—Anorexia—Capecitabine—kidney cancer	3.83e-05	0.000144	CcSEcCtD
Levofloxacin—Sinusitis—Doxorubicin—kidney cancer	3.81e-05	0.000143	CcSEcCtD
Levofloxacin—Agranulocytosis—Doxorubicin—kidney cancer	3.79e-05	0.000142	CcSEcCtD
Levofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	3.78e-05	0.00134	CbGpPWpGaD
Levofloxacin—Hypotension—Capecitabine—kidney cancer	3.75e-05	0.000141	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—PDHB—kidney cancer	3.74e-05	0.00132	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	3.73e-05	0.00132	CbGpPWpGaD
Levofloxacin—Vomiting—Gemcitabine—kidney cancer	3.72e-05	0.00014	CcSEcCtD
Levofloxacin—Bradycardia—Doxorubicin—kidney cancer	3.71e-05	0.00014	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—BRCA2—kidney cancer	3.71e-05	0.00131	CbGpPWpGaD
Levofloxacin—Rash—Gemcitabine—kidney cancer	3.69e-05	0.000139	CcSEcCtD
Levofloxacin—Dermatitis—Gemcitabine—kidney cancer	3.68e-05	0.000138	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—CDKN2B—kidney cancer	3.67e-05	0.0013	CbGpPWpGaD
Levofloxacin—Haemoglobin—Doxorubicin—kidney cancer	3.66e-05	0.000138	CcSEcCtD
Levofloxacin—Headache—Gemcitabine—kidney cancer	3.66e-05	0.000138	CcSEcCtD
Levofloxacin—Nausea—Vincristine—kidney cancer	3.66e-05	0.000138	CcSEcCtD
Levofloxacin—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.66e-05	0.000138	CcSEcCtD
Levofloxacin—Rhinitis—Doxorubicin—kidney cancer	3.65e-05	0.000137	CcSEcCtD
Levofloxacin—Haemorrhage—Doxorubicin—kidney cancer	3.64e-05	0.000137	CcSEcCtD
Levofloxacin—Hepatitis—Doxorubicin—kidney cancer	3.64e-05	0.000137	CcSEcCtD
Levofloxacin—Insomnia—Capecitabine—kidney cancer	3.63e-05	0.000137	CcSEcCtD
Levofloxacin—Hypoaesthesia—Doxorubicin—kidney cancer	3.63e-05	0.000136	CcSEcCtD
Levofloxacin—Pharyngitis—Doxorubicin—kidney cancer	3.62e-05	0.000136	CcSEcCtD
Levofloxacin—CYP1A2—Biological oxidations—GSTT1—kidney cancer	3.61e-05	0.00128	CbGpPWpGaD
Levofloxacin—Paraesthesia—Capecitabine—kidney cancer	3.61e-05	0.000136	CcSEcCtD
Levofloxacin—Hypersensitivity—Paclitaxel—kidney cancer	3.61e-05	0.000136	CcSEcCtD
Levofloxacin—Urinary tract disorder—Doxorubicin—kidney cancer	3.6e-05	0.000135	CcSEcCtD
Levofloxacin—Oedema peripheral—Doxorubicin—kidney cancer	3.59e-05	0.000135	CcSEcCtD
Levofloxacin—Connective tissue disorder—Doxorubicin—kidney cancer	3.58e-05	0.000135	CcSEcCtD
Levofloxacin—Dyspnoea—Capecitabine—kidney cancer	3.58e-05	0.000135	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.58e-05	0.00126	CbGpPWpGaD
Levofloxacin—Urethral disorder—Doxorubicin—kidney cancer	3.57e-05	0.000134	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—kidney cancer	3.55e-05	0.00125	CbGpPWpGaD
Levofloxacin—Dyspepsia—Capecitabine—kidney cancer	3.54e-05	0.000133	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	3.53e-05	0.00125	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	3.53e-05	0.00125	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CCBL1—kidney cancer	3.52e-05	0.00124	CbGpPWpGaD
Levofloxacin—Visual impairment—Doxorubicin—kidney cancer	3.51e-05	0.000132	CcSEcCtD
Levofloxacin—Asthenia—Paclitaxel—kidney cancer	3.51e-05	0.000132	CcSEcCtD
Levofloxacin—Decreased appetite—Capecitabine—kidney cancer	3.49e-05	0.000131	CcSEcCtD
Levofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	3.49e-05	0.00123	CbGpPWpGaD
Levofloxacin—Nausea—Gemcitabine—kidney cancer	3.47e-05	0.000131	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Capecitabine—kidney cancer	3.47e-05	0.00013	CcSEcCtD
Levofloxacin—Fatigue—Capecitabine—kidney cancer	3.46e-05	0.00013	CcSEcCtD
Levofloxacin—Pruritus—Paclitaxel—kidney cancer	3.46e-05	0.00013	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	3.45e-05	0.00122	CbGpPWpGaD
Levofloxacin—Erythema multiforme—Doxorubicin—kidney cancer	3.45e-05	0.00013	CcSEcCtD
Levofloxacin—Constipation—Capecitabine—kidney cancer	3.44e-05	0.000129	CcSEcCtD
Levofloxacin—Pain—Capecitabine—kidney cancer	3.44e-05	0.000129	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	3.43e-05	0.00121	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	3.43e-05	0.00121	CbGpPWpGaD
Levofloxacin—Eye disorder—Doxorubicin—kidney cancer	3.41e-05	0.000128	CcSEcCtD
Levofloxacin—Tinnitus—Doxorubicin—kidney cancer	3.4e-05	0.000128	CcSEcCtD
Levofloxacin—CYP1A2—Biological oxidations—PTGS1—kidney cancer	3.39e-05	0.0012	CbGpPWpGaD
Levofloxacin—Cardiac disorder—Doxorubicin—kidney cancer	3.38e-05	0.000127	CcSEcCtD
Levofloxacin—Flushing—Doxorubicin—kidney cancer	3.38e-05	0.000127	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	3.38e-05	0.0012	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	3.36e-05	0.00119	CbGpPWpGaD
Levofloxacin—Diarrhoea—Paclitaxel—kidney cancer	3.35e-05	0.000126	CcSEcCtD
Levofloxacin—Feeling abnormal—Capecitabine—kidney cancer	3.31e-05	0.000124	CcSEcCtD
Levofloxacin—Angiopathy—Doxorubicin—kidney cancer	3.31e-05	0.000124	CcSEcCtD
Levofloxacin—Immune system disorder—Doxorubicin—kidney cancer	3.29e-05	0.000124	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	3.29e-05	0.00116	CbGpPWpGaD
Levofloxacin—Gastrointestinal pain—Capecitabine—kidney cancer	3.29e-05	0.000124	CcSEcCtD
Levofloxacin—Mediastinal disorder—Doxorubicin—kidney cancer	3.28e-05	0.000124	CcSEcCtD
Levofloxacin—Chills—Doxorubicin—kidney cancer	3.27e-05	0.000123	CcSEcCtD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—BRAF—kidney cancer	3.26e-05	0.00115	CbGpPWpGaD
Levofloxacin—Arrhythmia—Doxorubicin—kidney cancer	3.26e-05	0.000122	CcSEcCtD
Levofloxacin—Dizziness—Paclitaxel—kidney cancer	3.24e-05	0.000122	CcSEcCtD
Levofloxacin—Alopecia—Doxorubicin—kidney cancer	3.22e-05	0.000121	CcSEcCtD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	3.22e-05	0.00114	CbGpPWpGaD
Levofloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	3.22e-05	0.00114	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	3.21e-05	0.00114	CbGpPWpGaD
Levofloxacin—Mental disorder—Doxorubicin—kidney cancer	3.19e-05	0.00012	CcSEcCtD
Levofloxacin—Urticaria—Capecitabine—kidney cancer	3.19e-05	0.00012	CcSEcCtD
Levofloxacin—Abdominal pain—Capecitabine—kidney cancer	3.18e-05	0.000119	CcSEcCtD
Levofloxacin—Body temperature increased—Capecitabine—kidney cancer	3.18e-05	0.000119	CcSEcCtD
Levofloxacin—Malnutrition—Doxorubicin—kidney cancer	3.17e-05	0.000119	CcSEcCtD
Levofloxacin—Erythema—Doxorubicin—kidney cancer	3.17e-05	0.000119	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—BIRC5—kidney cancer	3.17e-05	0.00112	CbGpPWpGaD
Levofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	3.17e-05	0.00112	CbGpPWpGaD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	3.15e-05	0.00112	CbGpPWpGaD
Levofloxacin—Flatulence—Doxorubicin—kidney cancer	3.13e-05	0.000118	CcSEcCtD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.12e-05	0.0011	CbGpPWpGaD
Levofloxacin—Tension—Doxorubicin—kidney cancer	3.11e-05	0.000117	CcSEcCtD
Levofloxacin—Vomiting—Paclitaxel—kidney cancer	3.11e-05	0.000117	CcSEcCtD
Levofloxacin—Dysgeusia—Doxorubicin—kidney cancer	3.11e-05	0.000117	CcSEcCtD
Levofloxacin—Rash—Paclitaxel—kidney cancer	3.09e-05	0.000116	CcSEcCtD
Levofloxacin—Dermatitis—Paclitaxel—kidney cancer	3.08e-05	0.000116	CcSEcCtD
Levofloxacin—Nervousness—Doxorubicin—kidney cancer	3.08e-05	0.000116	CcSEcCtD
Levofloxacin—Back pain—Doxorubicin—kidney cancer	3.07e-05	0.000115	CcSEcCtD
Levofloxacin—Headache—Paclitaxel—kidney cancer	3.07e-05	0.000115	CcSEcCtD
Levofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.06e-05	0.00108	CbGpPWpGaD
Levofloxacin—Muscle spasms—Doxorubicin—kidney cancer	3.05e-05	0.000115	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—PPAT—kidney cancer	3.05e-05	0.00108	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GLIPR1—kidney cancer	3.05e-05	0.00108	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	3.04e-05	0.00108	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.02e-05	0.00107	CbGpPWpGaD
Levofloxacin—Vision blurred—Doxorubicin—kidney cancer	2.99e-05	0.000112	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	2.99e-05	0.00106	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Capecitabine—kidney cancer	2.96e-05	0.000111	CcSEcCtD
Levofloxacin—Ill-defined disorder—Doxorubicin—kidney cancer	2.94e-05	0.000111	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	2.94e-05	0.00104	CbGpPWpGaD
Levofloxacin—Anaemia—Doxorubicin—kidney cancer	2.93e-05	0.00011	CcSEcCtD
Levofloxacin—Agitation—Doxorubicin—kidney cancer	2.92e-05	0.00011	CcSEcCtD
Levofloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.92e-05	0.00103	CbGpPWpGaD
Levofloxacin—Nausea—Paclitaxel—kidney cancer	2.91e-05	0.000109	CcSEcCtD
Levofloxacin—Asthenia—Capecitabine—kidney cancer	2.88e-05	0.000108	CcSEcCtD
Levofloxacin—Malaise—Doxorubicin—kidney cancer	2.86e-05	0.000108	CcSEcCtD
Levofloxacin—Vertigo—Doxorubicin—kidney cancer	2.85e-05	0.000107	CcSEcCtD
Levofloxacin—Syncope—Doxorubicin—kidney cancer	2.85e-05	0.000107	CcSEcCtD
Levofloxacin—Pruritus—Capecitabine—kidney cancer	2.84e-05	0.000107	CcSEcCtD
Levofloxacin—Leukopenia—Doxorubicin—kidney cancer	2.84e-05	0.000107	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—FH—kidney cancer	2.84e-05	0.001	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—APRT—kidney cancer	2.84e-05	0.001	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	2.82e-05	0.000998	CbGpPWpGaD
Levofloxacin—ABCB1—Allograft Rejection—IL2—kidney cancer	2.81e-05	0.000993	CbGpPWpGaD
Levofloxacin—Palpitations—Doxorubicin—kidney cancer	2.8e-05	0.000105	CcSEcCtD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	2.8e-05	0.000989	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.79e-05	0.000988	CbGpPWpGaD
Levofloxacin—Loss of consciousness—Doxorubicin—kidney cancer	2.79e-05	0.000105	CcSEcCtD
Levofloxacin—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.79e-05	0.000986	CbGpPWpGaD
Levofloxacin—Cough—Doxorubicin—kidney cancer	2.77e-05	0.000104	CcSEcCtD
Levofloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	2.75e-05	0.000975	CbGpPWpGaD
Levofloxacin—Diarrhoea—Capecitabine—kidney cancer	2.75e-05	0.000103	CcSEcCtD
Levofloxacin—Hypertension—Doxorubicin—kidney cancer	2.74e-05	0.000103	CcSEcCtD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—RAF1—kidney cancer	2.73e-05	0.000964	CbGpPWpGaD
Levofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.7e-05	0.000956	CbGpPWpGaD
Levofloxacin—Myalgia—Doxorubicin—kidney cancer	2.7e-05	0.000102	CcSEcCtD
Levofloxacin—Chest pain—Doxorubicin—kidney cancer	2.7e-05	0.000102	CcSEcCtD
Levofloxacin—Arthralgia—Doxorubicin—kidney cancer	2.7e-05	0.000102	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	2.7e-05	0.000955	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	2.7e-05	0.000954	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	2.7e-05	0.000954	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	2.7e-05	0.000954	CbGpPWpGaD
Levofloxacin—Anxiety—Doxorubicin—kidney cancer	2.69e-05	0.000101	CcSEcCtD
Levofloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.68e-05	0.000101	CcSEcCtD
Levofloxacin—Discomfort—Doxorubicin—kidney cancer	2.67e-05	0.0001	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—GPC3—kidney cancer	2.67e-05	0.000943	CbGpPWpGaD
Levofloxacin—Dizziness—Capecitabine—kidney cancer	2.66e-05	9.99e-05	CcSEcCtD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	2.64e-05	0.000935	CbGpPWpGaD
Levofloxacin—Dry mouth—Doxorubicin—kidney cancer	2.64e-05	9.93e-05	CcSEcCtD
Levofloxacin—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.61e-05	0.000924	CbGpPWpGaD
Levofloxacin—Confusional state—Doxorubicin—kidney cancer	2.61e-05	9.82e-05	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.6e-05	0.000921	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CA2—kidney cancer	2.59e-05	0.000917	CbGpPWpGaD
Levofloxacin—TOP2A—Circadian rythm related genes—TP53—kidney cancer	2.59e-05	0.000917	CbGpPWpGaD
Levofloxacin—Anaphylactic shock—Doxorubicin—kidney cancer	2.59e-05	9.74e-05	CcSEcCtD
Levofloxacin—Oedema—Doxorubicin—kidney cancer	2.59e-05	9.74e-05	CcSEcCtD
Levofloxacin—Infection—Doxorubicin—kidney cancer	2.57e-05	9.67e-05	CcSEcCtD
Levofloxacin—Vomiting—Capecitabine—kidney cancer	2.55e-05	9.6e-05	CcSEcCtD
Levofloxacin—Shock—Doxorubicin—kidney cancer	2.55e-05	9.58e-05	CcSEcCtD
Levofloxacin—Nervous system disorder—Doxorubicin—kidney cancer	2.54e-05	9.55e-05	CcSEcCtD
Levofloxacin—Thrombocytopenia—Doxorubicin—kidney cancer	2.54e-05	9.53e-05	CcSEcCtD
Levofloxacin—Rash—Capecitabine—kidney cancer	2.53e-05	9.52e-05	CcSEcCtD
Levofloxacin—Dermatitis—Capecitabine—kidney cancer	2.53e-05	9.52e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—ALAD—kidney cancer	2.53e-05	0.000894	CbGpPWpGaD
Levofloxacin—Tachycardia—Doxorubicin—kidney cancer	2.53e-05	9.5e-05	CcSEcCtD
Levofloxacin—Headache—Capecitabine—kidney cancer	2.52e-05	9.46e-05	CcSEcCtD
Levofloxacin—Skin disorder—Doxorubicin—kidney cancer	2.52e-05	9.46e-05	CcSEcCtD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.51e-05	0.000889	CbGpPWpGaD
Levofloxacin—CYP1A2—Biological oxidations—GSTP1—kidney cancer	2.5e-05	0.000886	CbGpPWpGaD
Levofloxacin—Hyperhidrosis—Doxorubicin—kidney cancer	2.5e-05	9.41e-05	CcSEcCtD
Levofloxacin—SLC22A2—Neuronal System—BRAF—kidney cancer	2.5e-05	0.000885	CbGpPWpGaD
Levofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	2.5e-05	0.000883	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	2.47e-05	0.000874	CbGpPWpGaD
Levofloxacin—Anorexia—Doxorubicin—kidney cancer	2.47e-05	9.28e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—ST3GAL2—kidney cancer	2.47e-05	0.000873	CbGpPWpGaD
Levofloxacin—Hypotension—Doxorubicin—kidney cancer	2.42e-05	9.1e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—ALDH1A1—kidney cancer	2.41e-05	0.000853	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ACY1—kidney cancer	2.4e-05	0.00085	CbGpPWpGaD
Levofloxacin—Nausea—Capecitabine—kidney cancer	2.39e-05	8.97e-05	CcSEcCtD
Levofloxacin—ABCB1—Allograft Rejection—VEGFA—kidney cancer	2.39e-05	0.000844	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.38e-05	0.000842	CbGpPWpGaD
Levofloxacin—SLC22A4—Transmembrane transport of small molecules—RAF1—kidney cancer	2.37e-05	0.00084	CbGpPWpGaD
Levofloxacin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.36e-05	0.000836	CbGpPWpGaD
Levofloxacin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.36e-05	8.87e-05	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—kidney cancer	2.35e-05	0.000831	CbGpPWpGaD
Levofloxacin—Insomnia—Doxorubicin—kidney cancer	2.34e-05	8.81e-05	CcSEcCtD
Levofloxacin—Paraesthesia—Doxorubicin—kidney cancer	2.33e-05	8.74e-05	CcSEcCtD
Levofloxacin—SLC22A2—Metabolism—SLC5A3—kidney cancer	2.31e-05	0.000818	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PGK1—kidney cancer	2.31e-05	0.000818	CbGpPWpGaD
Levofloxacin—Dyspnoea—Doxorubicin—kidney cancer	2.31e-05	8.68e-05	CcSEcCtD
Levofloxacin—Somnolence—Doxorubicin—kidney cancer	2.3e-05	8.66e-05	CcSEcCtD
Levofloxacin—CYP1A2—Biological oxidations—GSTM1—kidney cancer	2.3e-05	0.000814	CbGpPWpGaD
Levofloxacin—Dyspepsia—Doxorubicin—kidney cancer	2.28e-05	8.57e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	2.27e-05	0.000803	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—LDHB—kidney cancer	2.27e-05	0.000802	CbGpPWpGaD
Levofloxacin—Decreased appetite—Doxorubicin—kidney cancer	2.25e-05	8.46e-05	CcSEcCtD
Levofloxacin—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.24e-05	8.41e-05	CcSEcCtD
Levofloxacin—Fatigue—Doxorubicin—kidney cancer	2.23e-05	8.39e-05	CcSEcCtD
Levofloxacin—Pain—Doxorubicin—kidney cancer	2.21e-05	8.33e-05	CcSEcCtD
Levofloxacin—Constipation—Doxorubicin—kidney cancer	2.21e-05	8.33e-05	CcSEcCtD
Levofloxacin—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	2.18e-05	0.000772	CbGpPWpGaD
Levofloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	2.15e-05	0.000761	CbGpPWpGaD
Levofloxacin—Feeling abnormal—Doxorubicin—kidney cancer	2.13e-05	8.02e-05	CcSEcCtD
Levofloxacin—Gastrointestinal pain—Doxorubicin—kidney cancer	2.12e-05	7.96e-05	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle—CDKN2A—kidney cancer	2.1e-05	0.000743	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—RAF1—kidney cancer	2.09e-05	0.000739	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—kidney cancer	2.08e-05	0.000736	CbGpPWpGaD
Levofloxacin—Urticaria—Doxorubicin—kidney cancer	2.06e-05	7.74e-05	CcSEcCtD
Levofloxacin—Abdominal pain—Doxorubicin—kidney cancer	2.05e-05	7.7e-05	CcSEcCtD
Levofloxacin—Body temperature increased—Doxorubicin—kidney cancer	2.05e-05	7.7e-05	CcSEcCtD
Levofloxacin—ABCB1—Metabolism—PDHB—kidney cancer	2.04e-05	0.000723	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—kidney cancer	1.99e-05	0.000702	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.98e-05	0.000702	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	1.97e-05	0.000696	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CA9—kidney cancer	1.97e-05	0.000695	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.93e-05	0.000684	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CCBL1—kidney cancer	1.92e-05	0.00068	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ACY1—kidney cancer	1.92e-05	0.000679	CbGpPWpGaD
Levofloxacin—Hypersensitivity—Doxorubicin—kidney cancer	1.91e-05	7.17e-05	CcSEcCtD
Levofloxacin—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.91e-05	0.000674	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.87e-05	0.000661	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CDKN1B—kidney cancer	1.86e-05	0.000658	CbGpPWpGaD
Levofloxacin—Asthenia—Doxorubicin—kidney cancer	1.86e-05	6.99e-05	CcSEcCtD
Levofloxacin—Pruritus—Doxorubicin—kidney cancer	1.83e-05	6.89e-05	CcSEcCtD
Levofloxacin—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.78e-05	0.000628	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—CCND1—kidney cancer	1.78e-05	0.000628	CbGpPWpGaD
Levofloxacin—Diarrhoea—Doxorubicin—kidney cancer	1.77e-05	6.66e-05	CcSEcCtD
Levofloxacin—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.75e-05	0.00062	CbGpPWpGaD
Levofloxacin—Dizziness—Doxorubicin—kidney cancer	1.71e-05	6.44e-05	CcSEcCtD
Levofloxacin—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.68e-05	0.000596	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CRABP1—kidney cancer	1.67e-05	0.000591	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PPAT—kidney cancer	1.67e-05	0.000589	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GLIPR1—kidney cancer	1.67e-05	0.000589	CbGpPWpGaD
Levofloxacin—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.66e-05	0.000587	CbGpPWpGaD
Levofloxacin—Vomiting—Doxorubicin—kidney cancer	1.65e-05	6.19e-05	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—kidney cancer	1.64e-05	0.000579	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.64e-05	0.000579	CbGpPWpGaD
Levofloxacin—Rash—Doxorubicin—kidney cancer	1.63e-05	6.14e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—PDHB—kidney cancer	1.63e-05	0.000577	CbGpPWpGaD
Levofloxacin—Dermatitis—Doxorubicin—kidney cancer	1.63e-05	6.13e-05	CcSEcCtD
Levofloxacin—CYP1A2—Biological oxidations—POMC—kidney cancer	1.63e-05	0.000575	CbGpPWpGaD
Levofloxacin—Headache—Doxorubicin—kidney cancer	1.62e-05	6.1e-05	CcSEcCtD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MYC—kidney cancer	1.59e-05	0.000563	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—kidney cancer	1.56e-05	0.000551	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ITPR2—kidney cancer	1.55e-05	0.00055	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—FH—kidney cancer	1.55e-05	0.000548	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—APRT—kidney cancer	1.55e-05	0.000548	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.55e-05	0.000547	CbGpPWpGaD
Levofloxacin—Nausea—Doxorubicin—kidney cancer	1.54e-05	5.78e-05	CcSEcCtD
Levofloxacin—CYP1A2—Metabolism—CCBL1—kidney cancer	1.53e-05	0.000543	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.53e-05	0.000541	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.49e-05	0.000529	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ACY1—kidney cancer	1.48e-05	0.000524	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MAPK3—kidney cancer	1.46e-05	0.000518	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GPC3—kidney cancer	1.46e-05	0.000515	CbGpPWpGaD
Levofloxacin—SLC22A2—Neuronal System—MAPK1—kidney cancer	1.43e-05	0.000507	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MYC—kidney cancer	1.42e-05	0.000504	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.42e-05	0.000503	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CA2—kidney cancer	1.42e-05	0.000501	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ACHE—kidney cancer	1.42e-05	0.000501	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTT1—kidney cancer	1.42e-05	0.000501	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.42e-05	0.000501	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—MAPK1—kidney cancer	1.39e-05	0.000493	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.39e-05	0.000491	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ALAD—kidney cancer	1.38e-05	0.000488	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.37e-05	0.000486	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.35e-05	0.000478	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.35e-05	0.000477	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.35e-05	0.000477	CbGpPWpGaD
Levofloxacin—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	1.35e-05	0.000476	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SCARB1—kidney cancer	1.34e-05	0.000474	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.34e-05	0.000473	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.33e-05	0.000471	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PPAT—kidney cancer	1.33e-05	0.000471	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTGS1—kidney cancer	1.33e-05	0.00047	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.32e-05	0.000466	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.31e-05	0.000465	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.3e-05	0.000461	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PSMD7—kidney cancer	1.3e-05	0.000461	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.3e-05	0.00046	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SLC5A3—kidney cancer	1.26e-05	0.000447	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PGK1—kidney cancer	1.26e-05	0.000447	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PDHB—kidney cancer	1.26e-05	0.000446	CbGpPWpGaD
Levofloxacin—CYP3A4—Biological oxidations—POMC—kidney cancer	1.26e-05	0.000444	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—LDHB—kidney cancer	1.24e-05	0.000438	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—FH—kidney cancer	1.24e-05	0.000437	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—APRT—kidney cancer	1.24e-05	0.000437	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—BCHE—kidney cancer	1.23e-05	0.000437	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SLC5A5—kidney cancer	1.22e-05	0.000431	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.21e-05	0.000428	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CCBL1—kidney cancer	1.18e-05	0.000419	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—SLC2A1—kidney cancer	1.18e-05	0.000417	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.18e-05	0.000416	CbGpPWpGaD
Levofloxacin—TOP2A—Cell Cycle—TP53—kidney cancer	1.17e-05	0.000414	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GPC3—kidney cancer	1.16e-05	0.000411	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CA2—kidney cancer	1.13e-05	0.0004	CbGpPWpGaD
Levofloxacin—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.12e-05	0.000397	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.11e-05	0.000394	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ALAD—kidney cancer	1.1e-05	0.00039	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.08e-05	0.000383	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.08e-05	0.000381	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CA9—kidney cancer	1.07e-05	0.00038	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.06e-05	0.000375	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.05e-05	0.000372	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PPAT—kidney cancer	1.03e-05	0.000363	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.03e-05	0.000363	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.01e-05	0.000357	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PGK1—kidney cancer	1.01e-05	0.000357	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1e-05	0.000354	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—LDHB—kidney cancer	9.89e-06	0.00035	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTP1—kidney cancer	9.82e-06	0.000347	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—FH—kidney cancer	9.54e-06	0.000338	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—APRT—kidney cancer	9.54e-06	0.000338	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—ABCB1—kidney cancer	9.3e-06	0.000329	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	9.2e-06	0.000325	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CRABP1—kidney cancer	9.13e-06	0.000323	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—GSTM1—kidney cancer	9.03e-06	0.000319	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GPC3—kidney cancer	8.97e-06	0.000317	CbGpPWpGaD
Levofloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	8.9e-06	0.000315	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CA2—kidney cancer	8.73e-06	0.000309	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CA9—kidney cancer	8.57e-06	0.000303	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—CYP1A1—kidney cancer	8.56e-06	0.000303	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ALAD—kidney cancer	8.51e-06	0.000301	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ITPR2—kidney cancer	8.49e-06	0.0003	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.38e-06	0.000296	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.3e-06	0.000294	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ALDH1A1—kidney cancer	8.12e-06	0.000287	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.78e-06	0.000275	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PGK1—kidney cancer	7.78e-06	0.000275	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTT1—kidney cancer	7.74e-06	0.000274	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—ACHE—kidney cancer	7.74e-06	0.000274	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—LDHB—kidney cancer	7.63e-06	0.00027	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SCARB1—kidney cancer	7.33e-06	0.000259	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CRABP1—kidney cancer	7.29e-06	0.000258	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTGS1—kidney cancer	7.25e-06	0.000257	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PSMD7—kidney cancer	7.11e-06	0.000252	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ITPR2—kidney cancer	6.78e-06	0.00024	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—BCHE—kidney cancer	6.74e-06	0.000239	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SLC5A5—kidney cancer	6.66e-06	0.000236	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CA9—kidney cancer	6.62e-06	0.000234	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—SLC2A1—kidney cancer	6.43e-06	0.000228	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—POMC—kidney cancer	6.38e-06	0.000226	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.25e-06	0.000221	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTT1—kidney cancer	6.18e-06	0.000219	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ACHE—kidney cancer	6.18e-06	0.000219	CbGpPWpGaD
Levofloxacin—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.13e-06	0.000217	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SCARB1—kidney cancer	5.85e-06	0.000207	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTGS1—kidney cancer	5.79e-06	0.000205	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PSMD7—kidney cancer	5.68e-06	0.000201	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CRABP1—kidney cancer	5.63e-06	0.000199	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—BCHE—kidney cancer	5.38e-06	0.00019	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTP1—kidney cancer	5.37e-06	0.00019	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SLC5A5—kidney cancer	5.32e-06	0.000188	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ITPR2—kidney cancer	5.23e-06	0.000185	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—SLC2A1—kidney cancer	5.14e-06	0.000182	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTGS2—kidney cancer	5.09e-06	0.00018	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.98e-06	0.000176	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—GSTM1—kidney cancer	4.93e-06	0.000174	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ACHE—kidney cancer	4.77e-06	0.000169	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTT1—kidney cancer	4.77e-06	0.000169	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—CYP1A1—kidney cancer	4.67e-06	0.000165	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SCARB1—kidney cancer	4.51e-06	0.00016	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTGS1—kidney cancer	4.47e-06	0.000158	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PTEN—kidney cancer	4.44e-06	0.000157	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PSMD7—kidney cancer	4.38e-06	0.000155	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.35e-06	0.000154	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTP1—kidney cancer	4.28e-06	0.000152	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—BCHE—kidney cancer	4.15e-06	0.000147	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.1e-06	0.000145	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—ABCB1—kidney cancer	4.05e-06	0.000143	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.96e-06	0.00014	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—GSTM1—kidney cancer	3.94e-06	0.000139	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—CYP1A1—kidney cancer	3.73e-06	0.000132	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—POMC—kidney cancer	3.48e-06	0.000123	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTP1—kidney cancer	3.31e-06	0.000117	CbGpPWpGaD
Levofloxacin—SLC22A2—Metabolism—PIK3CA—kidney cancer	3.13e-06	0.000111	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—ABCB1—kidney cancer	3.13e-06	0.000111	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.07e-06	0.000108	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—GSTM1—kidney cancer	3.04e-06	0.000107	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.88e-06	0.000102	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—POMC—kidney cancer	2.78e-06	9.84e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTGS2—kidney cancer	2.78e-06	9.83e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PTEN—kidney cancer	2.42e-06	8.58e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTGS2—kidney cancer	2.22e-06	7.85e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—POMC—kidney cancer	2.15e-06	7.6e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PTEN—kidney cancer	1.94e-06	6.85e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTGS2—kidney cancer	1.71e-06	6.06e-05	CbGpPWpGaD
Levofloxacin—ABCB1—Metabolism—PIK3CA—kidney cancer	1.71e-06	6.05e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PTEN—kidney cancer	1.49e-06	5.28e-05	CbGpPWpGaD
Levofloxacin—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.37e-06	4.83e-05	CbGpPWpGaD
Levofloxacin—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.05e-06	3.73e-05	CbGpPWpGaD
